116 related articles for article (PubMed ID: 2556248)
21. Screening for hepatocellular carcinoma.
Haydon GH; Hayes PC
Eur J Gastroenterol Hepatol; 1996 Sep; 8(9):856-60. PubMed ID: 8889450
[TBL] [Abstract][Full Text] [Related]
22. Hepatocellular carcinoma (HCC) and diagnostic significance of A-fetoprotein (AFP).
Baig JA; Alam JM; Mahmood SR; Baig M; Shaheen R; Sultana I; Waheed A
J Ayub Med Coll Abbottabad; 2009; 21(1):72-5. PubMed ID: 20364746
[TBL] [Abstract][Full Text] [Related]
23. Alpha-fetoprotein reaction to Pisum sativum agglutinin in differentiation of benign liver diseases from hepatocellular carcinoma.
Yin ZF; Tu ZX; Cui ZF; Wu MC
Chin Med J (Engl); 1993 Aug; 106(8):615-8. PubMed ID: 7693403
[TBL] [Abstract][Full Text] [Related]
24. Novel fluorescence method for detection of α-L-fucosidase based on CdTe quantum dots.
Chen Z; Ren X; Meng X; Zhang Y; Chen D; Tang F
Anal Chem; 2012 May; 84(9):4077-82. PubMed ID: 22486298
[TBL] [Abstract][Full Text] [Related]
25. Alpha-l-Fucosidase Immunoassay for Early Detection of Hepatocellular Carcinoma.
Waidely E; Al-Youbi AO; Bashammakh AS; El-Shahawi MS; Leblanc RM
Anal Chem; 2017 Sep; 89(17):9459-9466. PubMed ID: 28727913
[TBL] [Abstract][Full Text] [Related]
26. Hepatocellualar carcinoma serum markers.
Bertino G; Ardiri A; Malaguarnera M; Malaguarnera G; Bertino N; Calvagno GS
Semin Oncol; 2012 Aug; 39(4):410-33. PubMed ID: 22846859
[TBL] [Abstract][Full Text] [Related]
27. Carbon dots and gold nanoparticles based immunoassay for detection of alpha-L-fucosidase.
Mintz K; Waidely E; Zhou Y; Peng Z; Al-Youbi AO; Bashammakh AS; El-Shahawi MS; Leblanc RM
Anal Chim Acta; 2018 Dec; 1041():114-121. PubMed ID: 30340683
[TBL] [Abstract][Full Text] [Related]
28. 5'-Nucleotide phosphodiesterase isozyme-V in hepatocellular carcinoma and other liver diseases.
Fujiyama S; Tsude K; Sakai M; Sato T
Hepatogastroenterology; 1990 Oct; 37(5):469-73. PubMed ID: 1701410
[TBL] [Abstract][Full Text] [Related]
29. Combined assessment of TGF-beta-1 and alpha-fetoprotein values improves specificity in the diagnosis of hepatocellular carcinoma and other chronic liver diseases in Malaysia.
Yasmin Anum MY; Looi ML; Nor Aini AH; Merican I; Wahidah A; Mohd Radzi AH; Nor Azizah A; Othman NH
Med J Malaysia; 2009 Sep; 64(3):223-7. PubMed ID: 20527273
[TBL] [Abstract][Full Text] [Related]
30. Use of serum PIVKA-II (DCP) determination for differentiation between benign and malignant liver diseases.
Lamerz R; Runge M; Stieber P; Meissner E
Anticancer Res; 1999; 19(4A):2489-93. PubMed ID: 10470180
[TBL] [Abstract][Full Text] [Related]
31. [Significance of Golgi glycoprotein 73, a new tumor marker in diagnosis of hepatocellular carcinoma: a primary study].
Mao YL; Yang HY; Xu HF; Sang XT; Lu X; Yang ZY; Zhang JC; Zhong SX; Huang JF; Zhang HB
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):948-51. PubMed ID: 18756964
[TBL] [Abstract][Full Text] [Related]
32. [Application of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma].
Jia HL; Xing XJ; Ye QH; Qin LX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Aug; 30(4):440-3. PubMed ID: 18795617
[TBL] [Abstract][Full Text] [Related]
33. Clinical application of determining serum AFP-IgM complexes for diagnosis of small hepatocellular carcinoma.
Jiang J; Wu C; Shen Y; Xu B; Zheng X; Li X; Xu N
Anticancer Res; 2011 Feb; 31(2):687-91. PubMed ID: 21378357
[TBL] [Abstract][Full Text] [Related]
34. [Comparative study of 3 serum markers of primary liver cancer: ferritin, alpha-fetoprotein and alpha-fucosidase].
Bourel M; Deugnier Y; Brissot P; Leray G; Le Gall JY
Bull Acad Natl Med; 1987 Mar; 171(3):359-64. PubMed ID: 2444315
[No Abstract] [Full Text] [Related]
35. [Diagnosis of hepatocellular carcinoma performed by searching for serologic tumor markers].
de Oliveira e Silva A; Roldan-Molina F; dos Santos TE; Santo GC; Miranda MP; Genzini T; Neves LB; D'Albuquerque LA
Arq Gastroenterol; 1990; 27(2):83-94. PubMed ID: 1709803
[TBL] [Abstract][Full Text] [Related]
36. [Evaluation of the combined assay of alpha-feto protein and gamma-glutamyl transpeptidase isoenzyme II in the diagnosis of primary hepatic carcinoma].
Ding S; Li H; Shun S
Zhonghua Nei Ke Za Zhi; 1995 Oct; 34(10):690-2. PubMed ID: 8731833
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P
J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
[TBL] [Abstract][Full Text] [Related]
38. [Preoperative serum α-1-fucosidase as an early-recurrent indicator for hepatocellular carcinoma following curative resection].
Zhou Y; Ma X; Wu J; Zhang C; Wang B; Song B; Guo W; Pan B
Zhonghua Yi Xue Za Zhi; 2014 Dec; 94(46):3623-8. PubMed ID: 25622951
[TBL] [Abstract][Full Text] [Related]
39. The clinical significance of serum alpha-L-fucosidase assay in hepatocellular carcinoma.
Yamamoto K; Yanagita T; Watanabe N; Morito F; Ozaki I; Motomura M; Ikuyama S; Setoguchi Y; Fujii S; Kariya T
Fukuoka Igaku Zasshi; 1988 Jun; 79(6):463-8. PubMed ID: 2852632
[No Abstract] [Full Text] [Related]
40. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G
Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
